RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 501.00
-13.00 (-2.53%)
Jun 3, 2026, 3:30 PM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 13.38 billion as of June 2, 2026. Its market cap has increased by 31.28% in one year.
Market Cap
13.38B
Enterprise Value
11.67B
Revenue
3.81B
Ranking
n/a
PE Ratio
240.20
Stock Price
501.00
Market Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has decreased from 19.90B to 13.38B, a decrease of -32.77%. That is a compound annual growth rate of -2.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 13.38B | -45.83% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnGes | 19.42B |
| StemRIM | 18.55B |
| Renascience | 18.25B |
| ReproCELL | 12.26B |
| Stella Pharma | 11.88B |
| CanBas | 11.68B |
| Immuno-Biological Laboratories | 10.05B |
| Nano Holdings | 9.77B |